U.S. flag

An official website of the United States government

NM_000371.4(TTR):c.221A>G (p.Glu74Gly) AND not specified

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 17, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001002179.8

Allele description [Variation Report for NM_000371.4(TTR):c.221A>G (p.Glu74Gly)]

NM_000371.4(TTR):c.221A>G (p.Glu74Gly)

Gene:
TTR:transthyretin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q12.1
Genomic location:
Preferred name:
NM_000371.4(TTR):c.221A>G (p.Glu74Gly)
HGVS:
  • NC_000018.10:g.31595140A>G
  • NG_009490.1:g.8374A>G
  • NM_000371.4:c.221A>GMANE SELECT
  • NP_000362.1:p.Glu74Gly
  • LRG_416t1:c.221A>G
  • LRG_416:g.8374A>G
  • NC_000018.9:g.29175103A>G
  • NM_000371.3:c.221A>G
Protein change:
E74G
Links:
dbSNP: rs1598845097
NCBI 1000 Genomes Browser:
rs1598845097
Molecular consequence:
  • NM_000371.4:c.221A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001160047ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Likely pathogenic
(Oct 17, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001160047.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The TTR c.221A>G; p.Glu74Gly variant, also known as Glu54Gly in the mature protein, is reported in the literature in multiple individuals affected with familial amyloid polyneuropathy (Durmus-Tekce 2016, Fontana 2015, Kim 2005, Pathak-Ray 2002, Reilly 1995, Saraiva 1995, Schanzer 2014). This variant is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. The glutamic acid at codon 74 is highly conserved, and is located within a region of the protein that is a hotspot for amyloidogenic variants (Saraiva 1995), but computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. Additionally, other amino acid substitutions at this codon (Asp, Gln, Lys) have been reported in individuals with familial amyloid polyneuropathy (Eriksson 2009, Togashi 1999, Torres-Courchoud 2017). Based on available information, the p.Glu74Gly variant is considered to be likely pathogenic. References: Durmus-Tekce H et al. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Neuromuscul Disord. 2016 Jul;26(7):441-6. Eriksson M et al. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid. Am J Surg Pathol. 2009 Jan;33(1):58-65. Fontana M et al.cDifferential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study. Radiology. 2015 Nov;277(2):388-97. Kim HS et al. An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene. Eur J Neurol. 2005 Aug;12(8):657-9. Pathak-Ray V et al. Vitreous amyloidosis and secondary glaucoma-a case report. Eye (Lond). 2002 Jul;16(4):492-4. Reilly MM et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain. 1995 Aug;118 ( Pt 4):849-56. Saraiva MJ et al. Transthyretin mutations in health and disease. Hum Mutat. 1995;5(3):191-6. Schanzer A et al. A woman with a rare p.Glu74Gly transthyretin mutation presenting exclusively with a rapidly progressive neuropathy: a case report. J Med Case Rep. 2014 Dec 4;8:403. Togashi S et al. An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54. Neurology. 1999 Aug 11;53(3):637-9. Torres-Courchoud I et al. Cardiac Involvement Secondary to a Familial Form of Transthyretin Amyloidosis Resulting From the Glu54Gln Mutation. Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):297-299.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024